MedTrace Logo

Evaluation of Serum Ages Levels in Patients With Endometriosis

NCT04886024 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 90

Last updated 2021-08-31

No results posted yet for this study

Summary

Serum AGES (Advanced Glycation End Products) levels of endometriosis patients are compared with a group of healthy volunteers of the same age.

Conditions

  • Endometriosis

Interventions

OTHER

Advanced Glycation End Products (AGEs)

Advanced Glycation End Products (AGEs) releated with energy metabolism, In this study, the possible relationship between the serum levels of Advanced Glycation End Products (AGEs) of endometriosis patients and the disease and its stage is evaluated.

Sponsors & Collaborators

  • Kanuni Sultan Suleyman Training and Research Hospital

    lead OTHER

Eligibility

Min Age
18 Years
Max Age
45 Years
Sex
FEMALE
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2020-12-05
Primary Completion
2021-07-20
Completion
2021-07-30

Countries

  • Turkey (Türkiye)

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT04886024 on ClinicalTrials.gov